Antibodies are the backbone of the immune systemcapable of targeting proteins associated with infection and disease. They are also vital tools for biomedical research, the development of diagnostic tests and for new therapeutic remedies.
Producing antibodies suitable for research however, has often been a difficult, costly and laborious undertaking.
Now, John Chaput and his colleagues at the Biodesign Institute at Arizona State University have developed a new way of producing antibody-like binding agents and rapidly optimizing their affinity for their target proteins. Such capture reagents are vital for revealing the subtleties of protein function, and may pave the way for improved methods of detecting and treating a broad range of diseases.
The team's results appear in today's issue of the journal ChemBioChem.
Antibodies are Y-shaped structures, capable of binding in two or more places with specific target proteins. Synthetic antibodies are much simpler forms that attempt to mimic this behavior. As Chaput explains, creating affinity reagents with strong binding properties can be accomplished by combining two weak affinity segments on a synthetic scaffold. The resulting affinity reagent, if properly constructed, can amplify the binding properties of the individual segments by two or three orders of magnitude.
"This dramatic change in affinity has the ability to transform ordinary molecules into a high affinity synthetic antibody," Chaput says. "Unfortunately, the chemistry used to make these reagents can be quite challenging and often requires a lot of trial-and-error. With NIH funding, my group has reduced the complexity of this problem to simple chemistry that is user friendly and easily amenable to high throughput automation. Such technology is absolutely necessary if we want to compete with traditional monoclonal antibody technology. "
Traditionally, antibodies for research have been extr
'/>"/>
| Contact: Joseph Caspermeyer joseph.caspermeyer@asu.edu Arizona State University Source:Eurekalert |
Related biology news :
1. U of M researchers use improved imaging technique; discover a better approach to diagnosing epilepsy
2. Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
3. New genetic map of potato may lead to improved crops
4. Nanowire-based sensors offer improved detection of volatile organic compounds
5. China needs improved administrative system for nuclear power safety
6. IOF calls for improved strategies to close the treatment gap and reduce future burden of fractures
7. NPL helps Senceive to offer improved monitoring of structural assets across the UK
8. NIST seeks improved recovery of samples from biohazard events
9. Recycling perlite: New, improved method saves resources
10. Detecting pathogens in waterways: An improved approach
11. Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |